Evidence map›Paper›PMID 29531075›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Progesterone activation of zebrafish mineralocorticoid receptor may influence growth of some transplanted tumors.

Yoshinao Katsu, Michael E Baker

Open access · bronzeAbstract readLetterComment
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Molecular evolution of the switch for progesterone and spironolactone from mineralocorticoid receptor agonist to antagonist.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  4. Article
  5. Reply to Katsu and Baker: Using zebrafish PDX to screen drug sensitivity of endocrine-dependent cancers.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Yoshinao KatsuDepartment of Biological Sciences, Graduate School of Life Science, Hokkaido University, 060-0810 Sapporo, Japan; ykatsu@sci.hokudai.ac.jp mbaker@ucsd.edu.ORCID 0000-0003-2625-4626
Michael E BakerDivsion of Nephrology, Department of Medicine, University of California, San Diego, La Jolla, CA 92093 ykatsu@sci.hokudai.ac.jp mbaker@ucsd.edu.ORCID 0000-0003-4387-3269
Hokkaido University · JPUniversity of California San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ProgesteroneReceptors, MineralocorticoidAldosteroneAnimalsHumansMineralocorticoid Receptor AntagonistsNeoplasmsZebrafishAldosteroneMineralocorticoid Receptor AntagonistsProgesteroneReceptors, Mineralocorticoid

Identifiers

PMID29531075
PMCPMC5879718
OpenAlexW2794414071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.